ATE248601T1 - Impfstoff gegen rotavirus infektionen enthaltend peptide des viralenterotoxines nsp4 - Google Patents

Impfstoff gegen rotavirus infektionen enthaltend peptide des viralenterotoxines nsp4

Info

Publication number
ATE248601T1
ATE248601T1 AT96923329T AT96923329T ATE248601T1 AT E248601 T1 ATE248601 T1 AT E248601T1 AT 96923329 T AT96923329 T AT 96923329T AT 96923329 T AT96923329 T AT 96923329T AT E248601 T1 ATE248601 T1 AT E248601T1
Authority
AT
Austria
Prior art keywords
nsp4
terotoxin
viral
vaccine against
containing peptides
Prior art date
Application number
AT96923329T
Other languages
English (en)
Inventor
Mary K Estes
Judith Ball
Peng Tiang
Original Assignee
Baylor College Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Medicine filed Critical Baylor College Medicine
Application granted granted Critical
Publication of ATE248601T1 publication Critical patent/ATE248601T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96923329T 1995-06-14 1996-06-14 Impfstoff gegen rotavirus infektionen enthaltend peptide des viralenterotoxines nsp4 ATE248601T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22095P 1995-06-14 1995-06-14
US62801496A 1996-04-04 1996-04-04
PCT/US1996/010523 WO1997000088A2 (en) 1995-06-14 1996-06-14 Rotavirus enterotoxin nsp4 and methods of using same

Publications (1)

Publication Number Publication Date
ATE248601T1 true ATE248601T1 (de) 2003-09-15

Family

ID=26667352

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96923329T ATE248601T1 (de) 1995-06-14 1996-06-14 Impfstoff gegen rotavirus infektionen enthaltend peptide des viralenterotoxines nsp4

Country Status (8)

Country Link
US (1) US6210682B1 (de)
EP (1) EP0833670B1 (de)
JP (1) JPH11507831A (de)
AT (1) ATE248601T1 (de)
AU (1) AU6387196A (de)
CA (1) CA2224697A1 (de)
DE (1) DE69629812T2 (de)
WO (1) WO1997000088A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6572862B1 (en) * 1989-11-08 2003-06-03 Baylor College Of Medicine Methods and reagents to detect and characterize Norwalk and related viruses
US6673355B1 (en) 1995-06-14 2004-01-06 Baylor College Of Medicine Rotavirus enterotoxin NSP4 and methods of using same
US7422747B2 (en) * 1997-10-07 2008-09-09 Loma Linda University Transgenic plant-based vaccines
US20050178729A1 (en) * 1999-07-30 2005-08-18 Rabie Hamid R. Maintenance cleaning for membranes
CA2427809A1 (en) * 2000-11-03 2002-05-10 Baylor College Of Medicine Rotavirus enterotoxin nsp4 and methods of using same
WO2002044330A2 (en) * 2000-12-01 2002-06-06 Wyeth Crystal structure of rotavirus nsp4 peptide
MX350541B (es) 2010-09-24 2017-09-08 Univ Florida Materiales y metodos para mejorar la funcion gastrointestinal.
SI2814508T1 (sl) * 2012-02-14 2017-10-30 Merial, Inc. Rotavirusna podenotska cepiva ter postopki njihove izdelave in uporaba
ES2691083T3 (es) * 2012-04-05 2018-11-23 University Of Florida Research Foundation, Inc. Composición para el tratamiento de fibrosis quística y la inducción de secreción de iones
CN102909136B (zh) * 2012-10-29 2014-07-09 江西理工大学 一种锂辉石矿的选矿方法
EP2968241B1 (de) 2013-03-11 2018-10-31 University of Florida Research Foundation, Inc. Materialien und verfahren zur verbesserung der lungenfunktion und zur vorbeugung und/oder behandlung von strahlungsinduzierten lungenkomplikationen
AU2016208999A1 (en) * 2015-01-23 2017-07-13 Medicago Inc. Rotavirus-like particle production in plants
CN111187606B (zh) * 2020-02-25 2022-06-14 江苏海洋大学 一种用于海水基可循环清洁压裂液的表面活性剂及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2483779A1 (fr) 1980-06-05 1981-12-11 Synthelabo Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins
US4341763A (en) 1981-03-10 1982-07-27 Smithkline-Rit Methods of vaccinating humans against rotavirus infection
US4745051A (en) 1983-05-27 1988-05-17 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
FR2551088B1 (de) 1983-08-29 1985-12-06 Pasteur Institut
US4636385A (en) 1985-02-15 1987-01-13 The Wistar Institute Of Anatomy & Biology Vaccine, method for its preparation, and use thereof in vaccinating humans against rotavirus infection
US4861864A (en) 1985-05-14 1989-08-29 Albert Einstein College of Medicine of Yeshiva University (a Div. of Yeshiva University) Rotavirus antigens
US4853333A (en) 1985-07-26 1989-08-01 American Home Products Corporation Production of rotavirus in yeast
US4704275A (en) 1985-08-26 1987-11-03 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against rotavirus diseases
EP0251467A3 (de) * 1986-06-20 1988-07-20 Abbott Laboratories Zusammensetzungen und Verfahren zum Gebrauch eines Haupt-Aussen-Kapsid-Proteins (VP7) des Rotavirus SA-11
US5186933A (en) 1986-12-30 1993-02-16 Baylor College Of Medicine Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system
US5147639A (en) 1990-06-19 1992-09-15 Ambico, Inc. Type-c rotavirus cultures and uses therefor
ATE171208T1 (de) * 1990-07-26 1998-10-15 Wistar Inst Impfstoff aus reassortiertem rotavirus
KR0171434B1 (ko) 1990-11-16 1999-02-01 윌리엄 케이. 슈버트 인체 로타바이러스, 백신 및 방법
US6780630B1 (en) * 1992-07-10 2004-08-24 Baylor College Of Medicine Parenteral immunization against rotavirus

Also Published As

Publication number Publication date
US6210682B1 (en) 2001-04-03
WO1997000088A2 (en) 1997-01-03
DE69629812D1 (de) 2003-10-09
JPH11507831A (ja) 1999-07-13
WO1997000088A3 (en) 1997-03-27
DE69629812T2 (de) 2004-04-01
EP0833670B1 (de) 2003-09-03
CA2224697A1 (en) 1997-01-03
EP0833670A2 (de) 1998-04-08
AU6387196A (en) 1997-01-15

Similar Documents

Publication Publication Date Title
NO20022531L (no) Vaksine for forebyggelse og behandling av Alzheimer- og amyloidrelaterte sykdommer
ATE248601T1 (de) Impfstoff gegen rotavirus infektionen enthaltend peptide des viralenterotoxines nsp4
DE69327534D1 (de) Impfstoffe gegen diphtherietoxin
AU2002302255A1 (en) Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
ATE144143T1 (de) Künstlicher impfstoff gegen aids-virus
DE69840383D1 (de) Ctl epitope des epstein-barr virus
HUP9801266A2 (hu) Multimer, rekombináns ureázvakcina
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
SI1140168T1 (en) Vaccination against cancer
ATE193974T1 (de) Chlamydia impfstoffen
DK0762895T3 (da) Syntetisk vaccine til beskyttelse mod infektion med human immundefektvirus
ES2143996T3 (es) Antigenos peptidicos del hcv y procedimiento para la determinacion del hcv.
DE60313437D1 (de) Mhc klasse i peptidepitope des humanen tumorassoziierten antigens 5t4
NL300112I2 (nl) Vaccin tegen dermatomycosis.
SE9700244D0 (sv) Novel antibacterial protein
DK0493575T3 (da) Vaccine af reassortant rotavirus
UA42741C2 (uk) Пептид маститної вакцини (варіанти), пептид складного антигенного представлення (варіанти), фармацевтична композиція (варіанти)
PT1194450E (pt) Vacina inactivada contra a calicivirose felina
DE69433057D1 (de) Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus
WO2002045743A3 (en) Hcv vaccines
DK0470989T3 (da) Anvendelse af monoklonale anti-beta2 mikroglobulin antistoffer
DE60022995D1 (de) Impfstoff
SE9600436D0 (sv) Vaccine against hantavirus
MXPA04000402A (es) Compuestos de tipo pirrol, composiciones que los contienen, y metodos que los emplean para el tratamiento de cancer y enfermedades virales y para causar inmunosupresion.
ATE212839T1 (de) Hämoregulatorische verbindungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties